vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and Symbotic Inc. (SYM). Click either name above to swap in a different company.
Symbotic Inc. is the larger business by last-quarter revenue ($630.0M vs $493.8M, roughly 1.3× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 0.4%, a 6.4% gap on every dollar of revenue. On growth, Symbotic Inc. posted the faster year-over-year revenue change (29.4% vs -1.7%). Over the past eight quarters, Symbotic Inc.'s revenue compounded faster (21.9% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Symbotic Inc. is an American robotics warehouse automation company based in Wilmington, Massachusetts.
MD vs SYM — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $630.0M |
| Net Profit | $33.7M | $2.6M |
| Gross Margin | — | 21.2% |
| Operating Margin | 9.9% | 1.0% |
| Net Margin | 6.8% | 0.4% |
| Revenue YoY | -1.7% | 29.4% |
| Net Profit YoY | 10.5% | 174.9% |
| EPS (diluted) | $0.40 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $630.0M | ||
| Q3 25 | $492.9M | $618.5M | ||
| Q2 25 | $468.8M | $592.1M | ||
| Q1 25 | $458.4M | $549.7M | ||
| Q4 24 | $502.4M | $486.7M | ||
| Q3 24 | $511.2M | $503.6M | ||
| Q2 24 | $504.3M | $491.9M | ||
| Q1 24 | $495.1M | $424.3M |
| Q4 25 | $33.7M | $2.6M | ||
| Q3 25 | $71.7M | $-3.6M | ||
| Q2 25 | $39.3M | $-5.9M | ||
| Q1 25 | $20.7M | $-3.9M | ||
| Q4 24 | $30.5M | $-3.5M | ||
| Q3 24 | $19.4M | $-2.5M | ||
| Q2 24 | $-153.0M | $-2.5M | ||
| Q1 24 | $4.0M | $-6.6M |
| Q4 25 | — | 21.2% | ||
| Q3 25 | — | 20.6% | ||
| Q2 25 | — | 18.2% | ||
| Q1 25 | — | 19.6% | ||
| Q4 24 | — | 16.4% | ||
| Q3 24 | — | 12.7% | ||
| Q2 24 | — | 13.7% | ||
| Q1 24 | — | 10.4% |
| Q4 25 | 9.9% | 1.0% | ||
| Q3 25 | 13.8% | -3.5% | ||
| Q2 25 | 12.8% | -6.2% | ||
| Q1 25 | 7.0% | -5.8% | ||
| Q4 24 | 7.8% | -5.1% | ||
| Q3 24 | 6.6% | -4.3% | ||
| Q2 24 | -31.3% | -5.1% | ||
| Q1 24 | 3.2% | -12.0% |
| Q4 25 | 6.8% | 0.4% | ||
| Q3 25 | 14.5% | -0.6% | ||
| Q2 25 | 8.4% | -1.0% | ||
| Q1 25 | 4.5% | -0.7% | ||
| Q4 24 | 6.1% | -0.7% | ||
| Q3 24 | 3.8% | -0.5% | ||
| Q2 24 | -30.3% | -0.5% | ||
| Q1 24 | 0.8% | -1.6% |
| Q4 25 | $0.40 | $0.02 | ||
| Q3 25 | $0.84 | $-0.04 | ||
| Q2 25 | $0.46 | $-0.05 | ||
| Q1 25 | $0.24 | $-0.04 | ||
| Q4 24 | $0.37 | $-0.03 | ||
| Q3 24 | $0.23 | $-0.03 | ||
| Q2 24 | $-1.84 | $-0.02 | ||
| Q1 24 | $0.05 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $1.8B |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $663.8M |
| Total Assets | $2.2B | $3.0B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $1.8B | ||
| Q3 25 | $340.1M | $1.2B | ||
| Q2 25 | $224.7M | $777.6M | ||
| Q1 25 | $99.0M | $954.9M | ||
| Q4 24 | $229.9M | $903.0M | ||
| Q3 24 | $103.8M | $727.3M | ||
| Q2 24 | $19.4M | $870.5M | ||
| Q1 24 | $8.0M | $901.4M |
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $663.8M | ||
| Q3 25 | $890.7M | $221.3M | ||
| Q2 25 | $833.8M | $210.8M | ||
| Q1 25 | $789.2M | $205.4M | ||
| Q4 24 | $764.9M | $196.5M | ||
| Q3 24 | $732.5M | $197.2M | ||
| Q2 24 | $706.5M | $418.7M | ||
| Q1 24 | $856.2M | $417.1M |
| Q4 25 | $2.2B | $3.0B | ||
| Q3 25 | $2.2B | $2.4B | ||
| Q2 25 | $2.1B | $1.8B | ||
| Q1 25 | $2.0B | $2.0B | ||
| Q4 24 | $2.2B | $1.7B | ||
| Q3 24 | $2.1B | $1.6B | ||
| Q2 24 | $2.0B | $1.6B | ||
| Q1 24 | $2.2B | $1.6B |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $191.5M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 3.39× | 73.61× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $191.5M | ||
| Q3 25 | $137.3M | $530.7M | ||
| Q2 25 | $137.2M | $-138.3M | ||
| Q1 25 | $-117.5M | $269.6M | ||
| Q4 24 | $133.0M | $205.0M | ||
| Q3 24 | $91.8M | $-99.4M | ||
| Q2 24 | $107.0M | $50.4M | ||
| Q1 24 | $-125.2M | $21.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $197.7M | ||
| Q3 24 | — | $-120.1M | ||
| Q2 24 | — | $33.5M | ||
| Q1 24 | — | $18.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 40.6% | ||
| Q3 24 | — | -23.9% | ||
| Q2 24 | — | 6.8% | ||
| Q1 24 | — | 4.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.5% | ||
| Q3 24 | — | 4.1% | ||
| Q2 24 | — | 3.4% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | 3.39× | 73.61× | ||
| Q3 25 | 1.91× | — | ||
| Q2 25 | 3.49× | — | ||
| Q1 25 | -5.66× | — | ||
| Q4 24 | 4.36× | — | ||
| Q3 24 | 4.72× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -31.03× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
SYM
| Systems | $590.3M | 94% |
| Operation Services | $28.8M | 5% |
| Software Maintenance And Support | $10.9M | 2% |
| Revision Of Prior Period Change In Accounting Principle Adjustment | $2.9M | 0% |
| Related Party | $1.1M | 0% |
